R1 RCM Inc Stock News

MURRAY, Utah, Dec. 31, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthca

New York State Teachers Retirement System lifted its holdings in R1 RCM Inc. (NASDAQ:RCM) by 12.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,459 shares of the healthcare providers stock after buying an additional 8,059 shares [] The post New York State Teachers Retirement System Boosts Stake in R1 RCM Inc. (NASDAQ:RCM) appeared first on ETF Daily News .

R1 RCM Inc. (NASDAQ:RCM) shares gapped down before the market opened on Thursday . The stock had previously closed at $24.04, but opened at $23.49. R1 RCM shares last traded at $24.13, with a volume of 2,965 shares changing hands. A number of research analysts have recently commented on RCM shares. Jefferies Financial Group started []

Shares of R1 RCM Inc. (NASDAQ:RCM) have earned a consensus rating of Buy from the ten analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokers that have updated []

R1 RCM Inc. found using ticker (RCM) have now 10 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 37 and 25.62 with a mean TP of 30.86. With the stocks previous close at 24.61 this would indicate that there is a potential upside of 25.4%. The day 50 moving average is 23.9 and the 200 day moving average is 23.05. The company has a market capitalisation of $6,676m. Find out more information at: https://www.r1rcm.com [stock_market_widget type="chart" symbol="RCM" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services.

Pacer Advisors Inc. lowered its holdings in shares of R1 RCM Inc. (NASDAQ:RCM) by 3.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,158 shares of the healthcare providers stock after selling 902 shares during the period. Pacer Advisors []

Equities research analysts expect that R1 RCM Inc. (NASDAQ:RCM) will report sales of $399.99 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for R1 RCMs earnings. The highest sales estimate is $400.60 million and the lowest is $398.67 million. R1 RCM reported sales of $328.40 million during the []

Parametric Portfolio Associates LLC lowered its position in shares of R1 RCM Inc. (NASDAQ:RCM) by 44.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,075 shares of the healthcare providers stock after selling 145,165 shares during the period. []

R1 RCM Inc. (NASDAQ:RCM) Investment analysts at Jefferies Financial Group issued their Q4 2021 earnings per share (EPS) estimates for R1 RCM in a research note issued on Wednesday, December 1st. Jefferies Financial Group analyst G. Santangelo forecasts that the healthcare provider will post earnings per share of $0.12 for the quarter. Jefferies Financial []

Jefferies Financial Group began coverage on shares of R1 RCM (NASDAQ:RCM) in a report published on Wednesday morning, Price Targets.com reports. The firm issued a buy rating and a $28.00 price objective on the healthcare providers stock. RCM has been the subject of several other research reports. JPMorgan Chase & Co. initiated coverage on R1 []

Equities analysts expect that R1 RCM Inc. (NASDAQ:RCM) will report $0.11 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have made estimates for R1 RCMs earnings, with estimates ranging from $0.08 to $0.15. R1 RCM reported earnings of $0.06 per share during the same quarter last year, which indicates a []

Walleye Trading LLC purchased a new position in shares of R1 RCM Inc. (NASDAQ:RCM) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,716 shares of the healthcare providers stock, valued at approximately $238,000. Other large investors also []

VisitPay to offer a seamless and complete payment experience for Adventist Health patients expanding the reach of R1’s Entri™ platform VisitPay to offer a seamless and complete payment experience

Credit Suisse AG grew its stake in shares of R1 RCM Inc. (NASDAQ:RCM) by 20.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,844 shares of the healthcare providers stock after purchasing an additional 20,899 shares during the quarter. Credit []

Wall Street analysts forecast that R1 RCM Inc. (NASDAQ:RCM) will post sales of $399.79 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for R1 RCMs earnings. The highest sales estimate is $400.40 million and the lowest is $398.67 million. R1 RCM reported sales of $328.40 million in []